Stockscreener 앱 받기
1.27
0.00%
0.00
시간 외 거래:
1.76
0.49
+38.58%
전일 마감가:
$1.27
열려 있는:
$1.29
하루 거래량:
42,895
Relative Volume:
0.32
시가총액:
$13.48M
수익:
$3,000
순이익/손실:
$-8.79M
주가수익비율:
-0.6038
EPS:
-2.1033
순현금흐름:
$-8.46M
1주 성능:
+7.63%
1개월 성능:
-7.30%
6개월 성능:
-40.09%
1년 성능:
-47.08%
1일 변동 폭
$1.265
$1.30
1주일 범위
$1.18
$1.32
52주 변동 폭
$1.00
$3.20
Biocardia Inc Stock (BCDA) Company Profile
명칭
Biocardia Inc
전화
650-226-0123
주소
320 SOQUEL WAY, SUNNYVALE, CA
BCDA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| 0.41 | 0 | 0 | 0 | 0 | 0.00 | |
GOODO
Gladstone Commercial Corporation
|
20.83 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.82 | 418.21M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
7.30 | 329.86M | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
48.05 | 0 | 0 | 0 | 0 | 0.00 |
|
QQQE
Direxion NASDAQ-100 Equal Weigh
|
105.25 | 0 | 0 | 0 | 0 | 0.00 |
Biocardia Inc Stock (BCDA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-04-16 | 다운그레이드 | Dawson James | Buy → Neutral |
Biocardia Inc 주식(BCDA)의 최신 뉴스
Can BioCardia Inc. stock deliver surprise earnings beat2026 world cup usa national team semifinals star players possession football odds analysis tactical review - Улправда
Bull Run: Why analysts raise outlook for BioCardia Inc 6JU0 stock2025 Market Outlook & Daily Profit Focused Stock Screening - moha.gov.vn
Profit Review: Will BioCardia Inc 6JU0 stock sustain uptrend momentumJuly 2025 Volume & Safe Capital Growth Stock Tips - moha.gov.vn
Is BioCardia Inc 6JU0 a good long term investmentEconomic Indicators Overview & Free Stay Ahead With Picks - earlytimes.in
BioCardia (BCDA) Stock Analysis Report | Financials & Insights - Benzinga
BioCardia advances CardiAMP therapy in Japan - MSN
Will BioCardia Inc. stock deliver long term returns2025 Technical Patterns & Daily Growth Stock Tips - Улправда
Will BioCardia Inc. (6JU0) stock keep high P E multiplesCEO Change & Daily Technical Forecast Reports - Улправда
Will BioCardia Inc. stock keep outperforming rivals2025 Winners & Losers & Weekly Top Performers Watchlists - Улправда
Why BioCardia Inc. stock remains on buy lists2025 Winners & Losers & Consistent Income Trade Ideas - Улправда
Is BioCardia Inc. (6JU0) stock prepared for digital transitionTake Profit & Fast Exit Strategy with Risk Control - Улправда
Why retail investors pile into BioCardia Inc. stock2025 Volume Leaders & Reliable Volume Spike Trade Alerts - Улправда
Why BioCardia Inc. (6JU0) stock is trending on social media2025 Technical Patterns & Technical Entry and Exit Tips - Улправда
Is BioCardia Inc. (6JU0) stock protected from inflationJuly 2025 Earnings & Precise Swing Trade Alerts - Улправда
Is BioCardia Inc. stock attractive for ETFsMarket Performance Recap & Daily Price Action Insights - Улправда
BioCardia (BCDA) registers 424,509 incentive plan shares after 2025 vote - Stock Titan
Meme Stocks: Will BioCardia Inc. stock deliver long term returnsJuly 2025 EndofMonth & Verified Entry Point Signals - Улправда
BioCardia first patient enrolled at Henry Ford Health for Phase 3 CardiAMP - MSN
CEO Altman Buys 1,100 ($1.4K) Of BioCardia Inc [BCDA] - TradingView — Track All Markets
BioCardia (BCDA) CEO and president discloses December insider share buys - Stock Titan
BioCardia (BCDA) Advances CardiAMP Therapy for Heart Failure in Japan - GuruFocus
Biocardia cell therapy to enter PMDA clinical consultation - marketscreener.com
BioCardia Advances CardiAMP Therapy in Japan - TipRanks
BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA - The Manila Times
BioCardia Advances CardiAMP Cell Therapy for Heart Failure with PMDA Consultation Completion - Quiver Quantitative
BioCardia, Inc Advances CardiAMP Cell Therapy in Japan - TradingView — Track All Markets
BioCardia (NASDAQ: BCDA) moves to PMDA consultation on heart failure therapy - Stock Titan
BioCardia (NASDAQ: BCDA) allowed to advance to formal PMDA consultation on CardiAMP HFrEF - Stock Titan
BioCardia appoints Slosman to its Board of Directors - MSN
US Market Wrap: How Akso Health Group Depositary Receipt stock compares to industry benchmarksMarket Trend Review & Proven Capital Preservation Tips - moha.gov.vn
Revenue Check: Why BioCardia Inc 6JU0 stock stays undervalued2025 Dividend Review & High Win Rate Trade Tips - moha.gov.vn
BioCardia (NASDAQ: BCDA) director Form 3 shows no securities owned - Stock Titan
VP Gillis Acquires 22,906 Of BioCardia Inc [BCDA] - TradingView — Track All Markets
BioCardia (NASDAQ:BCDA) Trading Up 4.4% – Here’s Why - Defense World
Can BioCardia Inc. (6JU0) stock surprise markets with earningsStop Loss & Verified Momentum Stock Watchlist - Newser
What MACD trends signal for BioCardia Inc. (6JU0) stockRate Hike & Scalable Portfolio Growth Ideas - Newser
Why institutional investors increase stakes in BioCardia Inc. (6JU0) stockJuly 2025 Market Mood & Momentum Based Trading Ideas - Newser
Will BioCardia Inc. (6JU0) stock outperform benchmarksMarket Trend Summary & AI Forecast Swing Trade Picks - Newser
How strong dollar benefits BioCardia Inc. (6JU0) stockJuly 2025 Fed Impact & AI Based Buy and Sell Signals - Newser
BioCardia appoints Marvin Slosman to board as Richard Krasno departs By Investing.com - Investing.com Canada
BioCardia Announces Election of New Board Director, Marvin Slosman and Completion of Term for Outgoing Director, Dr. Richard Krasno - The Globe and Mail
BioCardia Appoints Marvin Slosman to Board of Directors - MSN
Biocardia announces election of new board director - marketscreener.com
BioCardia appoints Marvin Slosman to board as Richard Krasno departs - Investing.com India
BioCardia (NASDAQ: BCDA) elects Marvin Slosman to board, honors Dr. Krasno - Stock Titan
Biocardia Inc (BCDA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.52%
0.07%
자본화:
|
볼륨(24시간):